Word: biosimilar
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...Federal Trade Commission (FTC), though, argued in June that giving biologics makers any period of exclusivity at all could actually stifle innovation. Biologics are so much more complex and expensive to produce than traditional drugs that the barriers to would-be "biosimilar" competitors are already high, the FTC said. Giving biologics further protection - particularly the 12 years of exclusivity that the industry wants - would merely encourage firms to tinker with what they have rather than drive them toward "new inventions to address unmet medical needs...
| 1 |